- Home
- World
- Oxford’s coronavirus vaccine trial hits roadblock; low community transmission leaves only 50% chance
Oxford’s coronavirus vaccine trial hits roadblock; low community transmission leaves only 50% chance
Of the 10 vaccine candidates that have progressed to human trials globally, six are in China and it is the only country to have a candidate now firmly into phase two of trials.
- FB
- TW
- Linkdin
 "<p>The much talked about Oxford University's vaccine trial to treat coronavirus patients has only a 50% chance of success because of low community transmission of COVID-19 in Britain.<br />
</p>")
<p>The much talked about Oxford University's vaccine trial to treat coronavirus patients has only a 50% chance of success because of low community transmission of COVID-19 in Britain.<br /> </p>
The much talked about Oxford University's vaccine trial to treat coronavirus patients has only a 50% chance of success because of low community transmission of COVID-19 in Britain.
<p>There are nearly 224 vaccines in development in various countries and institutes around the world where Oxford University's vaccine is considered among the leaders in the race.<br /> </p>
There are nearly 224 vaccines in development in various countries and institutes around the world where Oxford University's vaccine is considered among the leaders in the race.
<p>However, Prof Adrian Hill, director of the university's Jenner Institute, said an upcoming Oxford vaccine trial, involving 10,000 volunteers, threatened to return "no result" due to low transmission of COVID-19 in the community, The Sydney Morning Herald reported.</p>
However, Prof Adrian Hill, director of the university's Jenner Institute, said an upcoming Oxford vaccine trial, involving 10,000 volunteers, threatened to return "no result" due to low transmission of COVID-19 in the community, The Sydney Morning Herald reported.
<p>Given the declining rate of COVID-19, Prof Hill said that his team now faced a major hurdle, in coming up with a vaccine in the set deadline of September.<br /> </p>
Given the declining rate of COVID-19, Prof Hill said that his team now faced a major hurdle, in coming up with a vaccine in the set deadline of September.
<p>"It is a race, yes. But it is not a race against the other guys. It is a race against the virus disappearing, and against time," he said. "At the moment, there's a 50 per cent chance that we get no result at all."</p>
"It is a race, yes. But it is not a race against the other guys. It is a race against the virus disappearing, and against time," he said. "At the moment, there's a 50 per cent chance that we get no result at all."
<p><br /> "We are in the bizarre position of wanting COVID to stay, at least for a little while. But cases are declining," added Prof Hill as quoted by The Sydney Morning Herald.</p>
"We are in the bizarre position of wanting COVID to stay, at least for a little while. But cases are declining," added Prof Hill as quoted by The Sydney Morning Herald.
<p>Despite certain apprehensions, countries across the globe are rushing their vaccine projects, and some including China and the US have even announced a tentative date.</p>
Despite certain apprehensions, countries across the globe are rushing their vaccine projects, and some including China and the US have even announced a tentative date.
